Elite Pharmaceuticals (ELTP) EBITDA Margin (2010 - 2026)
Elite Pharmaceuticals' EBITDA Margin was 24.05% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 30.60 percentage points from 54.65% a year earlier and down 1.57 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) EBITDA Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Elite Pharmaceuticals' EBITDA Margin was 25.52% through Jun 30, 2026, down 11.03 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was 33.71%, up 8.93 percentage points from FY2025.
- EBITDA Margin has now increased for three consecutive fiscal years, with a five-year change of +20.24 percentage points (FY2021 to FY2026).
- In earlier fiscal years, EBITDA Margin was 24.78% in FY2025 (+3.40 pp), 21.39% in FY2024 (+6.88 pp), 14.50% in FY2023 (-4.96 pp) and 19.47% in FY2022 (+6.00 pp).
- Quarterly EBITDA Margin has moved between -0.50% (fiscal Q4 2023) and 54.65% (fiscal Q1 2026) over five years.
- Compared with a year earlier, EBITDA Margin was higher in five of the last eight quarters, with an average year-over-year change of +2.09 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was fiscal Q1 2026 (a gain of 32.39 percentage points); the worst was fiscal Q1 2027 (a drop of 30.60 percentage points).
- Per Business Quant data, ELTP's EBITDA Margin in the three fiscal quarters before Q1 2027 was 25.62% (Q4 2026), 29.38% (Q3 2026) and 23.37% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.85 Bn | 1,106.43 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 618.85 Bn | 537.37 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 368.52 Bn | 322.90 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.19 Bn | 262.18 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.14 Bn | 192.53 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.35 Bn | 165.54 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 39.16% |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | 24.41% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.41% |
| Mar 31, 2026 | 25.91% |
| Dec 31, 2025 | 29.76% |
| Sep 30, 2025 | 23.70% |
| Jun 30, 2025 | 54.95% |
| Mar 31, 2025 | 36.14% |
| Dec 31, 2024 | 10.65% |
| Sep 30, 2024 | 20.30% |
| Jun 30, 2024 | 22.81% |
| Mar 31, 2024 | 22.82% |
| Dec 31, 2023 | 24.90% |
| Sep 30, 2023 | 15.91% |
| Jun 30, 2023 | 21.50% |
| Mar 31, 2023 | -0.50% |
| Dec 31, 2022 | 24.61% |
| Sep 30, 2022 | 16.31% |
| Jun 30, 2022 | 17.19% |
| Mar 31, 2022 | 15.02% |
| Dec 31, 2021 | 23.71% |
| Sep 30, 2021 | 20.12% |
Elite Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();